Advancing treatments for rare diseases Together

Stephanie Carnesecchi

Stephanie Carnesecchi holds a PhD in Biology (University of Strasbourg, France). She moved to the Medical School of Geneva (Switzerland) to develop and manage pre-clinical and translational projects in different disease areas. In 2014, Stephanie joined GenKyoTex where she was responsible for pre-clinical, biomarker and signalling discovery projects spanning varied disease areas. Stephanie also lectures at the Medical School of Geneva.

At EspeRare, Stephanie contributes to the development of the biomarkers programme in Duchenne Muscular Dystrophy.

Stephanie Carnesecchi